Cargando…

The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency

A 24-year-old woman with antithrombin (AT) deficiency presented with right-sided pleuritic chest pain of five days duration with diagnosis of pulmonary embolism (PE) made at an outside hospital. After discussion of treatment options with the patient, her treatment was changed to rivaroxaban protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Gryn, Oscar J, Nguyen, Trivian, Frankova, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358900/
https://www.ncbi.nlm.nih.gov/pubmed/32670697
http://dx.doi.org/10.7759/cureus.8560
_version_ 1783558935811194880
author Gryn, Oscar J
Nguyen, Trivian
Frankova, Daniela
author_facet Gryn, Oscar J
Nguyen, Trivian
Frankova, Daniela
author_sort Gryn, Oscar J
collection PubMed
description A 24-year-old woman with antithrombin (AT) deficiency presented with right-sided pleuritic chest pain of five days duration with diagnosis of pulmonary embolism (PE) made at an outside hospital. After discussion of treatment options with the patient, her treatment was changed to rivaroxaban protocol. The case illustrates an appropriate treatment plan for patients with AT deficiency presenting with unprovoked PE, especially when prioritizing ease of use.
format Online
Article
Text
id pubmed-7358900
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-73589002020-07-14 The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency Gryn, Oscar J Nguyen, Trivian Frankova, Daniela Cureus Internal Medicine A 24-year-old woman with antithrombin (AT) deficiency presented with right-sided pleuritic chest pain of five days duration with diagnosis of pulmonary embolism (PE) made at an outside hospital. After discussion of treatment options with the patient, her treatment was changed to rivaroxaban protocol. The case illustrates an appropriate treatment plan for patients with AT deficiency presenting with unprovoked PE, especially when prioritizing ease of use. Cureus 2020-06-11 /pmc/articles/PMC7358900/ /pubmed/32670697 http://dx.doi.org/10.7759/cureus.8560 Text en Copyright © 2020, Gryn et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Gryn, Oscar J
Nguyen, Trivian
Frankova, Daniela
The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title_full The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title_fullStr The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title_full_unstemmed The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title_short The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
title_sort use of rivaroxaban for unprovoked pulmonary embolism in the setting of antithrombin deficiency
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358900/
https://www.ncbi.nlm.nih.gov/pubmed/32670697
http://dx.doi.org/10.7759/cureus.8560
work_keys_str_mv AT grynoscarj theuseofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency
AT nguyentrivian theuseofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency
AT frankovadaniela theuseofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency
AT grynoscarj useofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency
AT nguyentrivian useofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency
AT frankovadaniela useofrivaroxabanforunprovokedpulmonaryembolisminthesettingofantithrombindeficiency